Reach Your Targeted Audience

OFP reaches an audience of over 20,000 osteopathic family physicians throughout their career journey. We offer advertising within the PDF version of our journal, which is promoted to ACOFP members through email, social media, and newsletters, among other channels. Our journal publishes quarterly, in January, April, July, and September.

OFP is an ideal advertising platform for:

  • Employers seeking the best nationwide candidates
  • Pharmaceutical companies
  • Medical supply companies
  • Medical malpractice companies
  • Medical equipment companies
  • Diagnostic testing companies
  • Medical apparel companies

Rates

Our base rate is $1,750 for one full-page ad. Different rates may apply for ads that run in multiple issues, inserts, or other types of advertising.

For more details on pricing and advertising in Osteopathic Family Physician, contact Lisa Parisi, Development and Sales Manager.

Schedule

Publication dates are approximate and may shift slightly throughout the year.

IssueArt DeadlinePublication Date
Spring 2026March 16April 20
Summer 2026June 17July 10
Fall 2026September 22October 13
Winter 2027December 10January 10, 2027
    
    
    
    

Specifications

Artwork must meet the following specifications:

  • Size: 8 x 10.625"
  • File Type: Acceptable file types include high-resolution PDFs (exported from Adobe Illustrator or InDesign), INDD, and EPS.
  • Images: All images must be CYMK, at least 300 dpi and embedded in the submitted file.

 

 

Both electronic and print advertising submitted to the Osteopathic Family Physician (OFP) is reviewed by the ACOFP Editorial committee. ACOFP has the right to reject any advertisement for any reason, which need not be disclosed to the party submitting the advertisement. Advertising submitted to OFP should clearly identify the advertiser and the product or service being offered. If the advertisement promotes a pharmaceutical product, the full generic name of each active ingredient in the drug product should be clearly listed. OFP will not deliberately place print or electronic advertising opposite or adjacent to editorial content that discusses the product being advertised or that reports research on the advertised product and OFP will not publish advertisements that refer to an article in the same issue of a publication. Advertising submitted to OFP should be distinct from editorial and should not appear to be editorial; advertising must not be deceptive or misleading or make false claims. Any advertisements that include an indecent copy or contain negative content of a personal, racial, ethnic, medical, sexual orientation, or religious character will not be accepted.

Solicitation of advertising for OFP will be carried out to fulfill the objective of supporting awareness among health professionals and consumers of useful products and services and to contribute to the financial support of the publications. Acceptance of advertising in OFP shall not be construed, however, as an endorsement, approval, recommendation, warranty, or certification of the products or services by ACOFP or any group affiliated with it. Acceptance also does not imply responsibility on the part of ACOFP to ensure that the advertiser has complied with laws and regulations applicable to the marketing of the products. Acceptance of advertising does not imply that ACOFP has conducted an independent scientific review to validate product safety and efficacy or advertising claims. A company involved in an investigation or enforcement proceeding by a government agency with respect to claims made in the marketing of a product to be advertised in OFP must inform ACOFP of such investigation, proceeding, or litigation.

Specific Provisions:

  • Products or services must be safe and effective in the practice of medicine or to individuals and their families. A company whose product submitted for advertisement in the OFP journal is being evaluated for safety and effectiveness must so inform ACOFP.
  • Companies submitting new products for the advertisement may be required to provide information about product safety and effectiveness. If there is any question of safety or effectiveness, the appropriate staff person on the Editorial Committee should see a product sample before acceptance/rejection.
  • Advertisements for products that are subject to regulation by the Food & Drug Administration (FDA) will be accepted in OFP only if the products have met all FDA requirements to permit general marketing of the products.
  • Advertisements for products subject to FDA approval of both the product and the advertising may be accepted in OFP without further review.
  • Manufacturers whose products are subject to regulation by the FDA or Federal Trade Commission may be asked to submit a signed certification to ACOFP attesting that they have scientifically valid data on file to substantiate product claims or comparisons to other products.
  • Companies submitting advertisements for The Osteopathic Family Physician are required to indemnify the Association against claims based on the advertisements.